• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Genaera to begin late-stage clinical trials for squalamine

Article

Genaera Corp., Plymouth Meeting, PA, announced late last week that itexpects to begin late-stage clinical trials by early 2005 of its experimentaldrug squalamine to treat age-related macular degeneration (AMD).

Related Videos
© 2024 MJH Life Sciences

All rights reserved.